Non-incidental coamplification of Myc and ERBB2, and Myc and EGFR, in gastric adenocarcinomas

[1]  Y. Dobashi,et al.  Topoisomerase IIα gene amplification in gastric carcinomas: correlation with the HER2 gene. An immunohistochemical, immunoblotting, and multicolor fluorescence in situ hybridization study , 2006 .

[2]  S. Knuutila,et al.  Manifestation, mechanisms and mysteries of gene amplifications. , 2006, Cancer letters.

[3]  H. Joensuu,et al.  Amplification of genes encoding KIT, PDGFRα and VEGFR2 receptor tyrosine kinases is frequent in glioblastoma multiforme , 2005, The Journal of pathology.

[4]  J. Kountouras,et al.  New concepts of molecular biology on gastric carcinogenesis. , 2005, Hepato-gastroenterology.

[5]  H. Fujii,et al.  Amplification and overexpression of c‐erbB‐2, epidermal growth factor receptor, and c‐met in biliary tract cancers , 2005, The Journal of pathology.

[6]  Silvia Benvenuti,et al.  Gene copy number for epidermal growth factor receptor (EGFR) and clinical response to antiEGFR treatment in colorectal cancer: a cohort study. , 2005, The Lancet. Oncology.

[7]  Peter Schraml,et al.  Prognostic Relevance of Gene Amplifications and Coamplifications in Breast Cancer , 2004, Cancer Research.

[8]  Xiaoling Li,et al.  Protein overexpression and gene amplification of HER-2 and EGFR in colorectal cancers: an immunohistochemical and fluorescent in situ hybridization study , 2004, Modern Pathology.

[9]  H. Fujii,et al.  Expression of epidermal growth factor receptor in gastric carcinomas. , 2003, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[10]  M. Schmid,et al.  Murine pancreatic tumor cell line TD2 bears the characteristic pattern of genetic changes with two independently amplified gene loci , 2003, Oncogene.

[11]  D. Felsher,et al.  Genomically complex lymphomas undergo sustained tumor regression upon MYC inactivation unless they acquire novel chromosomal translocations. , 2003, Blood.

[12]  B. Dutrillaux,et al.  Induction of multiple double-strand breaks within an hsr by meganucleaseI-SceI expression or fragile site activation leads to formation of double minutes and other chromosomal rearrangements , 2002, Oncogene.

[13]  K. Kono,et al.  Status of c‐erbB‐2 in gastric adenocarcinoma: A comparative study of immunohistochemistry, fluorescence in situ hybridization and enzyme‐linked immuno‐sorbent assay , 2002, International journal of cancer.

[14]  C. Lindley,et al.  Pharmacology and therapeutic use of trastuzumab in breast cancer. , 2000, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[15]  Å. Borg,et al.  Amplification and deletion of topoisomerase IIalpha associate with ErbB-2 amplification and affect sensitivity to topoisomerase II inhibitor doxorubicin in breast cancer. , 2000, The American journal of pathology.

[16]  Seung-Moo Noh,et al.  Genetic alterations of gastric cancer: comparative genomic hybridization and fluorescence In situ hybridization studies. , 2000, Cancer genetics and cytogenetics.

[17]  Jorma Isola,et al.  Characterization of topoisomerase IIα gene amplification and deletion in breast cancer , 1999 .

[18]  T Takahashi,et al.  Gains, losses, and amplifications of genomic materials in primary gastric cancers analyzed by comparative genomic hybridization , 1999, Genes, chromosomes & cancer.

[19]  D. Felsher,et al.  Transient excess of MYC activity can elicit genomic instability and tumorigenesis. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[20]  K. Yanagihara,et al.  Amplification of c-myc, K-sam, and c-met in gastric cancers: detection by fluorescence in situ hybridization. , 1998, Laboratory investigation; a journal of technical methods and pathology.

[21]  S. Bautista,et al.  CCND1 and FGFR1 coamplification results in the colocalization of 11q13 and 8p12 sequences in breast tumor nuclei , 1998, Genes, chromosomes & cancer.

[22]  M. Kobayashi,et al.  Amplification of c-erbB-2 in gastric cancer: detection in formalin-fixed, paraffin-embedded tissue by fluorescence in situ hybridization. , 1998, Laboratory investigation; a journal of technical methods and pathology.

[23]  M. Maltoni,et al.  Gene amplification and proliferative kinetics in relation to prognosis of patients with gastric carcinoma , 1997, Cancer.

[24]  S. Mai,et al.  c-Myc overexpression associated DHFR gene amplification in hamster, rat, mouse and human cell lines. , 1996, Oncogene.

[25]  R. Seruca,et al.  Increasing levels of MYC and MET co-amplification during tumor progression of a case of gastric cancer. , 1995, Cancer genetics and cytogenetics.

[26]  D. Amadori,et al.  DNA amplification in human gastric carcinomas. , 1993, Cancer genetics and cytogenetics.

[27]  G. Wahl,et al.  Elimination of extrachromosomally amplified MYC genes from human tumor cells reduces their tumorigenicity. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[28]  M. Maltoni,et al.  Heterogeneous protooncogene amplification correlates with tumor progression and presence of metastases in gastric cancer patients. , 1990, Cancer research.

[29]  N. Copeland,et al.  A comprehensive genetic map of murine chromosome 11 reveals extensive linkage conservation between mouse and human. , 1989, Genetics.

[30]  P. Leder,et al.  Coexpression of MMTV/v-Ha-ras and MMTV/c-myc genes in transgenic mice: Synergistic action of oncogenes in vivo , 1987, Cell.

[31]  N. Nomura,et al.  DNA amplification of the c-myc and c-erbB-1 genes in a human stomach cancer. , 1986, Japanese journal of cancer research : Gann.

[32]  N. Nomura,et al.  Similarity of protein encoded by the human c-erb-B-2 gene to epidermal growth factor receptor , 1986, Nature.

[33]  R. Eisenman,et al.  Proteins encoded by the human c-myc oncogene: differential expression in neoplastic cells , 1984, Molecular and cellular biology.

[34]  P. Nowell,et al.  Association of amplified oncogene c-myc with an abnormally banded chromosome 8 in a human leukaemia cell line , 1983, Nature.

[35]  H. Varmus,et al.  Homogeneously staining chromosomal regions contain amplified copies of an abundantly expressed cellular oncogene (c-myc) in malignant neuroendocrine cells from a human colon carcinoma. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[36]  Y. Dobashi,et al.  Topoisomerase IIalpha gene amplification in gastric carcinomas: correlation with the HER2 gene. An immunohistochemical, immunoblotting, and multicolor fluorescence in situ hybridization study. , 2006, Human pathology.

[37]  竹花 卓夫.  Status of c-erbB-2 in gastric adenocarcinoma : A comparative study of immunohistochemistry, fluorescence in situ hybridization and enzyme-linked immuno-sorbent assay , 2003 .

[38]  C. Compton,et al.  AJCC Cancer Staging Manual , 2002, Springer New York.

[39]  Å. Borg,et al.  Characterization of topoisomerase II alpha gene amplification and deletion in breast cancer. , 1999, Genes, chromosomes & cancer.

[40]  J. Biegel,et al.  In vivo amplification of the PAX3-FKHR and PAX7-FKHR fusion genes in alveolar rhabdomyosarcoma. , 1996, Human molecular genetics.

[41]  A. Patel,et al.  myc function and regulation. , 1992, Annual review of biochemistry.

[42]  N. Kamada,et al.  Establishment and characterization of human signet ring cell gastric carcinoma cell lines with amplification of the c-myc oncogene. , 1991, Cancer research.

[43]  J. Cowell,et al.  Double minutes and homogeneously staining regions: gene amplification in mammalian cells. , 1982, Annual review of genetics.

[44]  T. Nagayo.  Tumours of the stomach. , 1973, IARC scientific publications.